1. Clinical application of ultra-widefield fundus autofluorescence
- Author
-
Amin Xu and Changzheng Chen
- Subjects
medicine.medical_specialty ,genetic structures ,Fundus Oculi ,Fundus (eye) ,Disease pathogenesis ,Retina ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Retinal Diseases ,Ophthalmology ,Humans ,Medicine ,Fluorescein Angiography ,business.industry ,Optical Imaging ,Retinal ,eye diseases ,Fundus autofluorescence ,Autofluorescence ,Search terms ,chemistry ,030221 ophthalmology & optometry ,Retinal imaging ,sense organs ,business ,030217 neurology & neurosurgery - Abstract
To review the basic principles of ultra-widefield fundus autofluorescence (UWF-FAF) and discuss its clinical application for a variety of retinal and choroidal disorders. A systematic review of the PubMed database was performed using the search terms “ultra-widefield,” “autofluorescence,” “retinal disease” and “choroidal disease.” UWF-FAF imaging is a recently developed noninvasive retinal imaging modality with a wide imaging range that can locate peripheral fundus lesions that traditional fundus autofluorescence cannot. Multiple commercially available ultra-widefield imaging systems, including Heidelberg Spectralis and Optomap Ultra-Widefield systems, are available to the clinician. Imaging by UWF-FAF is more comprehensive; it can reflect the content and distribution of the predominant ocular fluorophore in retinal pigment epithelial cells and evaluate the metabolic status of RPE of various retinal and choroidal disorders. UWF-FAF can detect abnormalities that traditional fundus autofluorescence cannot; therefore, it can be used to better elucidate disease pathogenesis, analyze genotype–phenotype correlations, diagnose and monitor disease.
- Published
- 2020